| 摘要 |
<p>The invention has revealed that human interleukin-15 (hIL-15) acts on the megakaryocyte thrombocyte system to accelerate the differentiation, mature and/or proliferation thereof to thereby accelerate the formation of thrombocytes, thus providing a medicinal composition efficacious in curing or preventing diseases accompanying thrombocytopenia and diseases accompanied by thrombocyte dysfunctions.</p> |
